4 Programs

Covaxin Efficacy 77.8% In Lancet Study; 65.2% Against Delta In Early Data – NDTV

admin
  1. Covaxin Efficacy 77.8% In Lancet Study; 65.2% Against Delta In Early Data  NDTV
  2. Bharat Biotech’s Covaxin Shows 70.8% Efficacy Against All COVID Variants in Phase 3  Republic World
  3. Covaxin Found To Be 77.8% Effective Against Covid In Lancet Study  NDTV
  4. Why India shouldn’t allow Covid-19 booster dose  Deccan Herald
  5. Indian Covid-19 vaccine ‘highly efficacious’ with no safety concerns: Lancet  Mint
  6. View Full coverage on Google News